Literature DB >> 15315526

Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres.

F Granella1, G Sances, G Allais, R E Nappi, A Tirelli, C Benedetto, B Brundu, F Facchinetti, G Nappi.   

Abstract

Aim of this study was to determine whether menstrual attacks differ from nonmenstrual attacks (NMA) as regards clinical features or response to abortive treatment in women affected by menstrually related migraine (MRM) referred to tertiary care centres. Sixty-four women with MRM were enrolled in a 2-month diary study. Perimenstrual attacks were split into three groups--premenstrual (PMA), menstrual (MA) and late menstrual (LMA)--and compared to nonmenstrual ones. Perimenstrual attacks were significantly longer than NMA. No other migraine attack features were found to differ between the various phases of the cycle. Migraine work-related disability was significantly greater in PMA and MA than in NMA. Acute attack treatment was less effective in perimenstrual attacks. Pain-free at 2 h after dosage was achieved in 13.5% of MA (OR 0.41; 95% CI 0.22, 0.76) vs. 32.9% of NMA. We concluded that, in MRM, perimenstrual attacks are longer and less responsive to acute attack treatment than NMA. Copyright 2004 Blackwell Publishing Ltd

Entities:  

Mesh:

Year:  2004        PMID: 15315526     DOI: 10.1111/j.1468-2982.2004.00741.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  57 in total

Review 1.  Treatment of perimenstrual migraine with triptans: an update.

Authors:  Barbara Casolla; Luana Lionetto; Serena Candela; Lidia D'Alonzo; Andrea Negro; Maurizio Simmaco; Paolo Martelletti
Journal:  Curr Pain Headache Rep       Date:  2012-10

2.  Menstrual migraine: therapeutic approaches.

Authors:  E Anne Macgregor
Journal:  Ther Adv Neurol Disord       Date:  2009-09       Impact factor: 6.570

3.  An Exploratory Study to Determine the Relationship between Cervical Dysfunction and Perimenstrual Migraines.

Authors:  Simone Horwitz; Aimee Stewart
Journal:  Physiother Can       Date:  2015       Impact factor: 1.037

Review 4.  Menstrual migraine: what it is and does it matter?

Authors:  Letizia Maria Cupini; Ilenia Corbelli; Paola Sarchelli
Journal:  J Neurol       Date:  2020-01-28       Impact factor: 4.849

Review 5.  Effects of the Menstrual Cycle on Neurological Disorders.

Authors:  Hannah J Roeder; Enrique C Leira
Journal:  Curr Neurol Neurosci Rep       Date:  2021-05-10       Impact factor: 5.081

Review 6.  Menstrual migraine.

Authors:  Ana Recober; Lynne O Geweke
Journal:  Curr Neurol Neurosci Rep       Date:  2005-03       Impact factor: 5.081

7.  Migraine in postmenopausal women and the risk of invasive breast cancer.

Authors:  Robert W Mathes; Kathleen E Malone; Janet R Daling; Scott Davis; Sylvia M Lucas; Peggy L Porter; Christopher I Li
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

Review 8.  Estrogen, migraine, and vascular risk.

Authors:  Gianni Allais; Giulia Chiarle; Silvia Sinigaglia; Gisella Airola; Paola Schiapparelli; Chiara Benedetto
Journal:  Neurol Sci       Date:  2018-06       Impact factor: 3.307

9.  Evolution of migraine-associated symptoms in menstrually related migraine following symptomatic treatment with almotriptan.

Authors:  Gianni Allais; Giancarlo Acuto; Chiara Benedetto; Giovanni D'Andrea; Licia Grazzi; Gian Camillo Manzoni; Franca Moschiano; Florindo d'Onofrio; Fabio Valguarnera; Gennaro Bussone
Journal:  Neurol Sci       Date:  2010-06       Impact factor: 3.307

10.  Optimizing prophylactic treatment of migraine: Subtypes and patient matching.

Authors:  Michel Dib
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.